Walter Ferlin,Nicolas Fischer,Greg Elson,Olivier Leger
申请号：
US15628037
公开号：
US20170291943A1
申请日:
2017.06.20
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to fully human antibodies, and fragments thereof, that bind to human interferon gamma (hIFNγ), thereby modulating the interaction between IFNγ and its receptor, IFNγ-R, and/or modulating the biological activities of IFNγ. The invention also relates to the use of such anti-IFNγ antibodies in the prevention or treatment of immune-related disorders and in the amelioration of a symptom associated with an immune-related disorder.
